-
Something wrong with this record ?
Validation of the Anti-Inflammatory Effect of Tenebrio Molitor Larva Oil in a Colitis Mouse Model
BM. Park, J. Lee, BG. Jung, BJ. Lee
Language English Country Czech Republic
Document type Journal Article
NLK
Free Medical Journals
from 2000
Freely Accessible Science Journals
from 2000
ProQuest Central
from 2005-01-01
Health & Medicine (ProQuest)
from 2005-01-01
ROAD: Directory of Open Access Scholarly Resources
from 2000
- MeSH
- Anti-Inflammatory Agents pharmacology therapeutic use MeSH
- Colitis * chemically induced drug therapy pathology MeSH
- Larva MeSH
- Disease Models, Animal MeSH
- Mice MeSH
- Dextran Sulfate toxicity MeSH
- Tenebrio * MeSH
- Colitis, Ulcerative * chemically induced drug therapy pathology MeSH
- Animals MeSH
- Check Tag
- Mice MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
Ulcerative colitis is caused by various external factors and is an inflammatory disease that causes decreased intestinal function. Tenebrio molitor larvae contain more than 30 % fat, and the fat component consists of 45 % oleic acid, 20 % linoleic acid and 20 % polyunsaturated fatty acids. In this study, after administering Tenebrio molitor larva oil (TMLO) in a dextran sodium sulphate (DSS)-induced ulcerative colitis mouse model, the pathological findings and inflammatory markers of colitis were analysed to assess whether a colitis mitigation effect was achieved. In the TMLO-administered group, the colon length increased, the spleen weight decreased, and the body weight increased compared with that in the DSS group. In addition, the disease activity index level decreased, the mRNA expression level of inflammatory cytokines in the colon decreased, and the myeloperoxidase activity level significantly decreased. Also, the activity of the NF-κB pathway involved in the regulation of the inflammatory response was lower in the TMLO group than in the DSS group. Taken together, these results suggest that TMLO suppresses occurrence of acute ulcerative colitis in the DSS mouse model. Therefore, TMLO has the potential to be developed as a health food for the prevention and treatment of ulcerative colitis.
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22029547
- 003
- CZ-PrNML
- 005
- 20230213133249.0
- 007
- ta
- 008
- 230113s2022 xr da f 000 0|eng||
- 009
- AR
- 035 __
- $a (PubMed)36384262
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Park, B. M. $u Department of Veterinary Infectious Diseases, College of Veterinary Medicine, Chonnam National University, Gwangju 61186, Korea
- 245 10
- $a Validation of the Anti-Inflammatory Effect of Tenebrio Molitor Larva Oil in a Colitis Mouse Model / $c BM. Park, J. Lee, BG. Jung, BJ. Lee
- 520 9_
- $a Ulcerative colitis is caused by various external factors and is an inflammatory disease that causes decreased intestinal function. Tenebrio molitor larvae contain more than 30 % fat, and the fat component consists of 45 % oleic acid, 20 % linoleic acid and 20 % polyunsaturated fatty acids. In this study, after administering Tenebrio molitor larva oil (TMLO) in a dextran sodium sulphate (DSS)-induced ulcerative colitis mouse model, the pathological findings and inflammatory markers of colitis were analysed to assess whether a colitis mitigation effect was achieved. In the TMLO-administered group, the colon length increased, the spleen weight decreased, and the body weight increased compared with that in the DSS group. In addition, the disease activity index level decreased, the mRNA expression level of inflammatory cytokines in the colon decreased, and the myeloperoxidase activity level significantly decreased. Also, the activity of the NF-κB pathway involved in the regulation of the inflammatory response was lower in the TMLO group than in the DSS group. Taken together, these results suggest that TMLO suppresses occurrence of acute ulcerative colitis in the DSS mouse model. Therefore, TMLO has the potential to be developed as a health food for the prevention and treatment of ulcerative colitis.
- 650 _2
- $a myši $7 D051379
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a síran dextranu $x toxicita $7 D016264
- 650 12
- $a Tenebrio $7 D013712
- 650 12
- $a ulcerózní kolitida $x chemicky indukované $x farmakoterapie $x patologie $7 D003093
- 650 _2
- $a larva $7 D007814
- 650 12
- $a kolitida $x chemicky indukované $x farmakoterapie $x patologie $7 D003092
- 650 _2
- $a modely nemocí na zvířatech $7 D004195
- 650 _2
- $a antiflogistika $x farmakologie $x terapeutické užití $7 D000893
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Lee, J. $u Biology Department at Morrissey College of Arts and Sciences, Boston College, Chestnut Hill, MA 02467, USA
- 700 1_
- $a Jung, B. G. $u Department of Pulmonary Immunology, Center for Pulmonary and Infectious Diseases Control, University of Texas Health Science Center at Tyler, Tyler, Texas 75708, USA
- 700 1_
- $a Lee, B. J. $u Department of Veterinary Infectious Diseases, College of Veterinary Medicine, Chonnam National University, Gwangju 61186, Korea
- 773 0_
- $w MED00011004 $t Folia biologica $x 0015-5500 $g Roč. 68, č. 2 (2022), s. 50-58
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/36384262 $y Pubmed
- 856 41
- $u https://fb.cuni.cz/file/6215/fb2022a0007.pdf $y plný text volně přístupný
- 910 __
- $a ABA008 $b A 970 $c 89 $y p $z 0
- 990 __
- $a 20230113 $b ABA008
- 991 __
- $a 20230213133246 $b ABA008
- 999 __
- $a ok $b bmc $g 1897125 $s 1180872
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2022 $b 68 $c 2 $d 50-58 $e - $i 0015-5500 $m Folia biologica (Praha) $n Folia biol. (Praha) $x MED00011004
- LZP __
- $b NLK138 $a Pubmed-20230113